These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32181563)

  • 1. Developments in siRNA Modification and Ligand Conjugated Delivery To Enhance RNA Interference Ability.
    Maguregui A; Abe H
    Chembiochem; 2020 Jul; 21(13):1808-1815. PubMed ID: 32181563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery.
    Mokhtarieh AA; Cheong S; Kim S; Chung BH; Lee MK
    Biochim Biophys Acta; 2012 Jul; 1818(7):1633-41. PubMed ID: 22465072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-Engineering RNA Molecules into Therapeutic Agents.
    Egli M; Manoharan M
    Acc Chem Res; 2019 Apr; 52(4):1036-1047. PubMed ID: 30912917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipophilic 2'-O-Acetal Ester RNAs: Synthesis, Thermal Duplex Stability, Nuclease Resistance, Cellular Uptake, and siRNA Activity after Spontaneous Naked Delivery.
    Biscans A; Bertrand JR; Dubois J; Rüger J; Vasseur JJ; Sczakiel G; Dupouy C; Debart F
    Chembiochem; 2016 Nov; 17(21):2054-2062. PubMed ID: 27569765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-responsive, reversibly-crosslinked thiolated cationic helical polypeptides for efficient siRNA encapsulation and delivery.
    Zheng N; Song Z; Liu Y; Zhang R; Zhang R; Yao C; Uckun FM; Yin L; Cheng J
    J Control Release; 2015 May; 205():231-9. PubMed ID: 25683619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twin disulfides as opportunity for improving stability and transfection efficiency of oligoaminoethane polyplexes.
    Klein PM; Müller K; Gutmann C; Kos P; Krhac Levacic A; Edinger D; Höhn M; Leroux JC; Gauthier MA; Wagner E
    J Control Release; 2015 May; 205():109-19. PubMed ID: 25553827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing polymer hydrophobicity for ligand presentation and siRNA delivery in dual function CXCR4 inhibiting polyplexes.
    Wang Y; Li J; Chen Y; Oupický D
    Biomater Sci; 2015 Jul; 3(7):1114-23. PubMed ID: 26146552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and Application of Peptide-siRNA Nanoparticles from Disulfide-Constrained Cyclic Amphipathic Peptides for the Functional Delivery of Therapeutic Oligonucleotides to the Lung.
    Welch JJ; Dean DA; Nilsson BL
    Methods Mol Biol; 2021; 2208():49-67. PubMed ID: 32856255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent progress in chemically modified siRNAs.
    Gaglione M; Messere A
    Mini Rev Med Chem; 2010 Jun; 10(7):578-95. PubMed ID: 20500149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemical modification: the key to clinical application of RNA interference?
    Corey DR
    J Clin Invest; 2007 Dec; 117(12):3615-22. PubMed ID: 18060019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent conjugation of oligonucleotides with cell-targeting ligands.
    Alam MR; Ming X; Nakagawa O; Jin J; Juliano RL
    Bioorg Med Chem; 2013 Oct; 21(20):6217-23. PubMed ID: 23777829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical and structural modifications of RNAi therapeutics.
    Ku SH; Jo SD; Lee YK; Kim K; Kim SH
    Adv Drug Deliv Rev; 2016 Sep; 104():16-28. PubMed ID: 26549145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actively-targeted polyion complex micelles stabilized by cholesterol and disulfide cross-linking for systemic delivery of siRNA to solid tumors.
    Oe Y; Christie RJ; Naito M; Low SA; Fukushima S; Toh K; Miura Y; Matsumoto Y; Nishiyama N; Miyata K; Kataoka K
    Biomaterials; 2014 Sep; 35(27):7887-95. PubMed ID: 24930854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the siRNA passenger strand by 5-nitroindole dramatically reduces its off-target effects.
    Zhang J; Zheng J; Lu C; Du Q; Liang Z; Xi Z
    Chembiochem; 2012 Sep; 13(13):1940-5. PubMed ID: 22887813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of surface properties on liposomal siRNA delivery.
    Xia Y; Tian J; Chen X
    Biomaterials; 2016 Feb; 79():56-68. PubMed ID: 26695117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. siRNA stabilization prolongs gene knockdown in primary T lymphocytes.
    Mantei A; Rutz S; Janke M; Kirchhoff D; Jung U; Patzel V; Vogel U; Rudel T; Andreou I; Weber M; Scheffold A
    Eur J Immunol; 2008 Sep; 38(9):2616-25. PubMed ID: 18792414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.